Esomeprazole for young children with autism
Treatments studied
Part of Mental health clinical trials.
This Phase 2 study tests whether esomeprazole helps children with autism. It looks at children who are generally healthy, take stable medicines, and can reliably attend visits so their care team can track changes during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 2 to 6 years old
- Your child has a confirmed autism diagnosis using standard autism assessments
- Your child can swallow the study medicine
- You can reliably bring your child to all clinic visits and provide trustworthy behavior ratings
- Your child’s other medications stay the same for at least 2 weeks (or 4 weeks if taking fluoxetine), and you won’t change autism-related support therapies during the open-label part
- Your child has no major ongoing medical problems that make participation unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This Phase 2 study tests whether diphenhydramine improves sleep in children with autism who have significant sleep problems. It requires sleep monitoring (watch data and sleep testing) and checking for side effects to see if the treatment is safe and helpful.
This Phase 2 study tests zolpidem (a sleep medicine) to help children with autism sleep better. It will check sleep changes using sleep testing and to confirm zolpidem is safe for this age group.
This Phase 2 study tests whether suvorexant helps improve sleep in children and teens with autism who have significant sleep trouble. It may help reduce behaviors related to poor sleep by changing how the brain promotes sleep.
This trial tests whether buspirone, a medication that helps with anxiety, can reduce anxiety in children and teens with autism. It is a 12-week study where participants receive buspirone or a placebo (a pill with no medicine) to see if it improves anxiety symptoms.
Hear when a new Autism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.